Peer Review History

Original SubmissionDecember 31, 2024
Decision Letter - Mergan Naidoo, Editor

Dear Dr. Frezgi,

There are some major methodological flaws identified by one of the reviewers that needs to be addressed before we can consider this manuscript for publication. Please address the concerns on the way the data was analysed. 

Please submit your revised manuscript by May 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.-->--> -->-->3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.-->?>

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: Yes

**********

Reviewer #1:  Thank you for the opportunity to review the submission, and for conducting this important piece of research.

I think this article needs lots of work prior to meeting PLoS publication criteria.

Scientific method

- Research question is not clearly answered

- A couple of results mentioned in Discussion [200-1] do not Appear in Results

English language

- Use of perinatal vs. neonatal

- uniformity of CD vs. CS

- provide definitions of abbreviations (COR, AOR)

- what is VCD [100]

- univariable vs. univariate

- provide definitions of abortion and extremely premature

- risk vs. likelihood

Statistics

- Difficult to interpret in places (especially multivariate analyses - unclear what is being isolated to highlight effect of exposure of interest)

- No sample size calculation

- Unclear why 1:2 ratio of case:control

- Median is mentioned (how is it relevant)

- Mean should be presented with SD

- it may have been better to exclude multiple pregnancies

Ethics

- I think the ethics statement in the proforma should refer to the approval by the Research Ethics committee

Obtetric issues

- Unclear if maternal morbidity referred to in [64] is immediate vs. long-term. Also unclear what the nature of maternal morbidity related to VBD is

- What is your reason for using the birth strata you used

- Can you comment on the significance of the decrease in VBD over the study period, and the potential reason?

Citations

- Many listed as invalid

Limitations

- I feel there are more than are mentioned

Reviewer #2:  Thank you for an interesting study.

The results need to be noted.

What I missed it the fact whether the breech deliveries ("cases") had a foetal heart on admission in labour or not. i.e. Were all fresh stillbirths. That should be confirmed and discussed at the relevant positions.

In the discussion I also missed the argument that the increased rate of stillbirth may be related to the relatively poor experience of vaginal breech deliveries of the current clinicians?

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Adam Konrad Asghar

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Thank you for your interesting comments really helped us to reshape our article.

Attachments
Attachment
Submitted filename: Authors respones final.docx
Decision Letter - Mergan Naidoo, Editor

Dear Dr. Frezgi,

Thank you for submitting your revised manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

We look forward to receiving your revised manuscript.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: Thank you for a detailed rebuttal.

I would suggest minor revisions as follows:

1. See lines 85/86. As previously suggested, use perinatal OR neonatal. Title now says Perinatal, but neonatal is used twice in these lines.

2. Choose either multivariable or multivariate https://pmc.ncbi.nlm.nih.gov/articles/PMC3518362/

3. Suggest listing a lack of a sample size calculation as a limitation. Same with decision to use 1:2 case:control. Your argument makes logical sense, but we are not sure if it makes statistical sense.

4. Median is still mentioned (line 110)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Adam Konrad Asghar

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 2

Reviewers comments Authors response

Reviewer #1

1. See lines 85/86. As previously suggested, use perinatal OR neonatal. Title now says Perinatal, but neonatal is used twice in these lines. Thank you. Arrangements have being made.

2. Choose either multivariable or multivariate https://pmc.ncbi.nlm.nih.gov/articles/PMC3518362/

Thank you. Arrangements have being made.

3. Suggest listing a lack of a sample size calculation as a limitation. Same with decision to use 1:2 case: control. Your argument makes logical sense, but we are not sure if it makes statistical sense. Added in limitation part with explanation.

But, the choice of 1:2 ratio of cases to controls was based on the idea that it was easy to recruit cases and controls with no extra cost, and the outcome was considered more common event. For this reason we didn’t add in limitation part.

4. Median is still mentioned (line 110)

Arrangements have being made.

Attachments
Attachment
Submitted filename: Authors respones final 16-07-25.docx
Decision Letter - Mergan Naidoo, Editor

Dear Dr. Frezgi,

1. See lines 85/86. As previously suggested, use perinatal OR neonatal. Title now says Perinatal, but neonatal is used twice in these lines.

2. Choose either multivariable or multivariate https://pmc.ncbi.nlm.nih.gov/articles/PMC3518362/

3. Suggest listing a lack of a sample size calculation as a limitation. Same with decision to use 1:2 case:control. Your argument makes logical sense, but we are not sure if it makes statistical sense.

Please submit your revised manuscript by Sep 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

We look forward to receiving your revised manuscript.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 3

Reviewers comments Authors response

Reviewer #1

1. See lines 85/86. As previously suggested, use perinatal OR neonatal. Title now says Perinatal, but neonatal is used twice in these lines. Thank you. Change have being made.

2. Choose either multivariable or multivariate https://pmc.ncbi.nlm.nih.gov/articles/PMC3518362/

Thank you. Arrangements have being made.

3. Suggest listing a lack of a sample size calculation as a limitation. Same with decision to use 1:2 case: control. Your argument makes logical sense, but we are not sure if it makes statistical sense. Added in limitation part with explanation.

But, the choice of 1:2 ratio of cases to controls was based on the idea that it was easy to recruit cases and controls with no extra cost, and the outcome was considered more common event. For this reason we didn’t add in limitation part.

4. Median is still mentioned (line 110)

Change have being made.

Attachments
Attachment
Submitted filename: Authors respones final 15-08-25.docx
Decision Letter - Mergan Naidoo, Editor

Perinatal Outcome of Vaginal Breech Delivery in Orotta National Referral Teaching Hospital, Eritrea, 2024; a Case Control Study.

PONE-D-24-59072R3

Dear Dr. Okbu Frezgi

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Mergan Naidoo, Editor

PONE-D-24-59072R3

PLOS ONE

Dear Dr. Frezgi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Mergan Naidoo

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .